Clinical Trial Update: Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial comparing oral topotecan to intravenous docetaxel in pretreated, advanced non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Hycamtin (Topotecan)
• Taxotere (docetaxel)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Non-Small-Cell Lung Cancer | Phase 3 | Status: COMPLETED